In Zetia pay-for-delay suit against Merck, Glenmark, district court should mull efficiency of joinder, Fourth Circuit says
Merck and Glenmark have succeeded in their bid to have a federal appeals court decertify a class of plaintiffs accusing them of engaging in an illegal pay-for-delay deal insulating cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article